Clincosm LogoSign in Get a demo

Esophageal Cancer

Showing NaN - NaN of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States

Recruiting
  • Advanced or Metastatic Solid Tumors
  • +11 more
  • Tucson, Arizona
  • +11 more
Dec 2, 2022

Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • New Haven, Connecticut
  • +12 more
Nov 3, 2022

Esophageal Cancer Trial in Houston (Proton Beam Therapy (PBT), Intensity Modulated Radiation Therapy (IMRT), Questionnaires)

Active, not recruiting
  • Esophageal Cancer
  • Proton Beam Therapy (PBT)
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 11, 2022

Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)

Completed
Has Results
  • Prostate Cancer
  • +4 more
  • NY-ESO-1 Plasmid DNA Cancer Vaccine
  • New York, New York
  • +1 more
Oct 3, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022

Esophageal Cancer, Esophagogastric Junction Cancer Trial in Worldwide (Autologous genetically modified ADP-A2M4CD8 cells)

Recruiting
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Autologous genetically modified ADP-A2M4CD8 cells
  • Duarte, California
  • +33 more
Aug 23, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)

Recruiting
  • Advanced Solid Tumor
  • +18 more
  • PT199
  • Anti-PD-1 monoclonal antibody
  • Huntersville, North Carolina
  • +2 more
Aug 10, 2022

Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T

Active, not recruiting
  • Urinary Bladder Cancer
  • +9 more
  • Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
  • Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
  • Miami, Florida
  • +10 more
Aug 9, 2022

Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

Active, not recruiting
  • Solid Tumor, Adult
  • +4 more
  • Birmingham, Alabama
  • +24 more
Aug 5, 2022

Metastatic Solid Tumors, Esophageal Cancer, NSCLC Trial in Houston, San Antonio, Toronto (M1231)

Recruiting
  • Metastatic Solid Tumors
  • +2 more
  • Houston, Texas
  • +2 more
Jul 29, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Grand Rapids, Michigan
  • +2 more
Jul 18, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Esophageal Cancer Trial in Houston, Seattle (CryoBalloon™ Full Ablation System, CryoBalloon™ Swipe Ablation System)

Completed
Has Results
  • Esophageal Cancer
  • CryoBalloon™ Full Ablation System
  • CryoBalloon™ Swipe Ablation System
  • Houston, Texas
  • +1 more
Apr 21, 2022

Bladder Cancer, Head and Neck Squamous Cell Carcinoma, Cancer of the Salivary Gland Trial in Houston (CAdVEC)

Recruiting
  • Bladder Cancer
  • +9 more
  • CAdVEC
  • Houston, Texas
    Baylor St. Luke's Medical Center
Feb 17, 2022

Oncology, Breast Cancer, Prostate Cancer Trial in Worldwide (Radiation therapy)

Recruiting
  • Oncology
  • +37 more
  • Radiation therapy
  • Houston, Texas
  • +7 more
Aug 23, 2021

Esophageal Cancer Trial in Houston (drug, radiation, procedure)

Completed
Has Results
  • Esophageal Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 12, 2021

NSCLC, Head Neck Cancer, Esophageal Cancer Trial in United States (JAB-3068)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Denver, Colorado
  • +3 more
Mar 25, 2021

Triple Negative Breast Cancer, Head & Neck Cancer, Esophageal Cancer Trial in Worldwide (PCA062)

Completed
  • Triple Negative Breast Cancer
  • +2 more
  • Houston, Texas
  • +6 more
Dec 16, 2020

Neoadjuvant Chemoradiotherapy for Esophageal Cancer

Completed
  • Esophageal Cancer
  • MRI and PET-CT
  • Houston, Texas
  • +1 more
Nov 13, 2020

Esophageal Cancer Trial in Houston (Everolimus, LDE 225)

Completed
  • Esophageal Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 10, 2020

Esophageal Cancer Trial in Houston (Radiation Therapy)

Completed
  • Esophageal Cancer
  • Radiation Therapy
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 20, 2020